These studies demonstrated that SSA administration results in increased blood glucose and suppressed insulin in rats, and increased blood glucose after sulfonylurea‐induced hypoglycemia in humans.12, 13, 22, 23. This evidence concerns the gene INS and Hypoglycemia.